Alemtuzumab-induced thyroid disease: A Danish cohort study
Juliana Frohnert Hansen(Amager Hospital), Ulla Feldt‐Rasmussen(Copenhagen University Hospital), Finn Sellebjerg(Kaiser Permanente), Melinda Magyari(University of Copenhagen), Åse Krogh Rasmussen(Steno Diabetes Centers)
Cited by 5
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293